c="Ehlers-Danlos syndrome II" 1:21 1:23||t="problem"||cui="C0013720"||tot="Ehlers-Danlos Syndrome"||ns="-756"
c="Ehlers-Danlos Syndrome II" 2:12 2:14||t="problem"||cui="C0013720"||tot="Ehlers-Danlos Syndrome"||ns="-756"
c="100-base pair insertion" 2:50 2:52||t="treatment"||cui="C0021107"||tot="Implantation procedure"||ns="-812"
c="G substitution" 2:75 2:76||t="problem"||cui="C1555721"||tot="Substitution - ActClass"||ns="-861"
c="proband secreted collagen" 2:196 2:198||t="treatment"||cui="C0009325"||tot="Collagen"||ns="-827"
c="alpha chain composition" 2:204 2:206||t="test"||cui="C0486616"||tot="Composition"||ns="-827"
c="proband dermal biopsy" 2:250 2:252||t="test"||cui="C0150866"||tot="Biopsy of skin procedure"||ns="-867"
c="osteogenesis imperfecta" 2:294 2:295||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
c="type V collagen" 2:317 2:319||t="treatment"||cui="C0009335"||tot="Collagen Type V"||ns="-1000"
